期刊文献+

二肽基肽酶Ⅳ抑制剂体外筛选模型的建立及应用 被引量:17

Establishment and application of screening method for DPPIV inhibitors in vitro
下载PDF
导出
摘要 目的建立二肽基肽酶Ⅳ抑制剂的筛选模型。方法以Gly-Pro-PNA为反应底物,通过发色底物法检测DPPIV的活性,对酶量、底物浓度、最佳温度、pH及反应时间进行了优化。结果确定反应条件为酶量0.5U.L-1、底物浓度0.262μmol·L-1、温度37℃、pH8.2。在上述反应条件下对多种中药进行了筛选,发现中药水蛭、茯神、密蒙花提取物具有DPPIV抑制作用。结论此方法可作为DPPIV抑制剂的体外筛选模型。 Aim To develop a model for screening DPPIV inhibitor from Chinese Herbal medicine. Methods With GlyPro-PNA as a substrate,DPPⅣ activity was assayed by the chromogenic substrate. The concentration of DPPIV and Gly-Pro- PNA, temperature, pH and reaction time were optimized. Resuits The optimal enzymatic reaction system was as follows: DPPIV 0. 5 U·L^-1 , Gly-Pro-PNA 0. 262umol·L^-1 , 37%,pH 8.2, reaction for 60 min. Further more, many kinds of herbal abstracts were screened and some had the DPPIV inhibitory function, such as Leech, Poria cum Radix Pini and Buddleja officinalis Maxim. Conclusion The model can be used to screen for DPPⅣ inhibitors in vitro.
出处 《中国药理学通报》 CAS CSCD 北大核心 2009年第3期411-414,共4页 Chinese Pharmacological Bulletin
基金 国家高技术研究发展计划(863计划)重点资助项目(No2007AA021506) 教育部新世纪优秀人才支持计划资助项目(NoNCET-07-0380)
关键词 DPPⅣ抑制剂 比色法 DPPⅣ inhibitor colorimetry
  • 相关文献

参考文献10

  • 1张志珍,毛积芳,刘智慧.二肽酶Ⅳ的结构与功能[J].生命的化学,2001,21(5):381-384. 被引量:7
  • 2Holst J J, Deacon C F. Glucagon-like peptide 1 and inhibitors of dipeptidyl peptidase IV in the treatment of type 2 diabetes mellitus [ J ]. Curr Opin Pharmacol,2004,4:589 - 96.
  • 3Nagatsu T, Hino M, Fuyamada H, et at. New chromogenicsubstratesfor x-prolyldipeptidyl -aminopeptidase [ J]. Anal Biochem, 1976,74:466 - 76.
  • 4Pascual I, Lopez A, Gomez H, et al. Screening of inhibitors of porcine dipeptidyl peptidase IV activity in aqueous extracts from marine organisms[ J]. Enzyme Microb Technol ,2007 , 40 :414 - 9.
  • 5Nobuyuki Y, Tadashi N, Takashi I, et al. E3024,3-but-2-ynyl-5- methyl-2-piperazin-1-yl-3,5-dihydro-4H-imidazo [ 4,5-d] pyridazin-4-one tosylate, is a novel, selective and eompetitivedipeptidylpeptidase- Ⅳ inhibitor [ J ]. Eur J Pharmacol,2006,548 : 181 - 7.
  • 6Inger B,Jurgen J, Xin C, et al. IV catalyzed peptide truncation Inhibition of dipeptidyl-peptidase by Vildagliptin ( ( 2S ) - / [ ( 3- hydroxyadamantan-1-yl) amino { acetyl } -pyrrolidine-2-carbonitrile ] [ J ]. Biochemical pharmacology, 2005,70 : 134 - 43.
  • 7刘彬,齐云,王敏,蔡润兰,宋杨.一种磷脂酶A_2抑制剂体外筛选方法的建立[J].中国药理学通报,2006,22(7):890-892. 被引量:5
  • 8苏衍进,祝海滨.茯神汤方治疗糖尿病38例临床体会[J].陕西中医学院学报,2006,29(3):21-22. 被引量:9
  • 9马宇鹏,张中新,张延英,李继霞,李广远.中药降糖胰生胶囊对实验性糖尿病动物模型的影响[J].第四军医大学学报,2006,27(13):1160-1162. 被引量:7
  • 10李海岛,冯苏秀,叶儒,郭洪祝,果德安.密蒙花正丁醇提取物对糖尿病大鼠血糖和醛糖还原酶的影响[J].中草药,2008,39(1):87-90. 被引量:19

二级参考文献43

共引文献42

同被引文献189

引证文献17

二级引证文献68

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部